Skip to main content
Neuropsychiatric Disease and Treatment logoLink to Neuropsychiatric Disease and Treatment
. 2026 Jan 8;22:579710. doi: 10.2147/NDT.S579710

Traditional Chinese Medicine Ameliorates Depression via the Gut-Brain Axis: A Review Focus on NLRP3/TLR4-Mediated Inflammatory Pathways and Gut Microbiota Modulation

Longfei Che 1, Jiaming Xie 2, Chunlei Xia 1, Qinming Yu 3,
PMCID: PMC12998633  PMID: 41858422

Abstract

Objective

Depression, a global mental disorder, is linked to gut-brain axis (GBA) dysfunction. This review explores how traditional Chinese medicine (TCM)—including single herbs (eg, Astragalus membranaceus, Lycium barbarum), herbal formulas (eg, Xiaoyaosan, Xiaochaihu Decoction), and acupuncture—alleviates depression via the GBA, focusing on neuroscience-relevant mechanisms (inflammation, neurotrophy).

Methods

A systematic literature search was conducted on PubMed, China National Knowledge Infrastructure (CNKI), and Embase from database inception to July 2025. Keywords included [“Traditional Chinese Medicine” or “TCM” or “herb” or “herbal extracts” or “Chinese herbal formulas”], [“depression” or “Depressive like behavior”], [“immune regulation”], [“inflammatory reaction”], [“neuroregeneration” or “nerve” or “neurotransmitter”]. Including peer-reviewed studies on human/animal models, articles that do not meet the requirements are excluded. A total of 307 eligible studies were included.

Results

TCM regulates gut microbiota composition—eg, increasing Lactobacillus and Bifidobacterium while reducing pathogenic taxa. Mechanistically, TCM inhibits pro-inflammatory pathways: herbs (eg, Astragalus membranaceus) and formulas (eg, Xiaoyaosan) downregulate IL-6, TNF-α, and IL-1β via suppressing NLRP3 inflammasome and TLR4/NF-κB signaling. They also enhance anti-inflammatory IL-10, elevate neurotransmitters (5-HT, DA), and upregulate BDNF. Acupuncture mirrors these effects, reducing plasma IL-6/TNF-α and restoring microbial balance to improve depressive behaviors.

Conclusion

TCM alleviates depression by integrating gut microbiota modulation, inflammatory suppression, and neuroprotection through the GBA. This review highlights TCM’s potential as a safe, alternative therapy for depression and identifies directions for standardized, large-scale clinical validation.

Keywords: traditional chinese medicine, Depression, gut microbiota, gut-brain axis, inflammatory reaction, immune regulation, neuroregeneration

Introduction

The Gut-Brain Axis (GBA) refers to a bidirectional communication network between the gut microbiota and the central nervous system, which has gradually gained attention in the research of psychological disorders such as depression.1 Depression is a global mental health crisis: the World Health Organization (WHO) estimates it affects 280 million people worldwide (3.8% of the global population), with 5% of adults suffering from major depressive disorder (MDD).2,3 It is the leading cause of disability globally, imposing substantial economic burdens (exceeding $2 trillion annually) and increasing the risk of suicide—accounting for over 700,000 deaths each year.4,5 Its pathological mechanism is complex, involving genetics, environment, neuroinflammation, and neurotransmitter imbalance, with GBA dysfunction emerging as a key contributor.6

Conventional treatments for depression primarily rely on pharmacotherapy (eg, selective serotonin reuptake inhibitors, SSRIs) and psychotherapy (eg, cognitive-behavioral therapy, CBT). However, these approaches have notable limitations: SSRIs often cause side effects (gastrointestinal distress, sexual dysfunction, weight gain) that lead to 30–50% of patients discontinuing treatment;7 approximately 30% of MDD patients are refractory to first-line drugs.8 Psychotherapy, while effective, is limited by high costs, poor accessibility in low- and middle-income countries, and reliance on trained professionals. Thus, there is an urgent need to explore safe, accessible alternative therapies.

In traditional Chinese medicine (TCM) theory, intestinal health is regarded as an important component of overall health.9 TCM aims to improve the intestinal environment by regulating visceral functions and balancing yin and yang (A core TCM theory describing two opposing yet complementary forces that maintain bodily homeostasis; TCM treats depression by balancing yin-yang)., thereby influencing mental health.10 In recent years, a growing number of studies have begun to explore the role of TCM in regulating the gut microbiota, especially in the treatment of depression.11–13 Zhi-Zi-Chi decoction, a TCM formula consisting of Gardenia jasminoides and fermented soybean, with effects of clearing heat and relieving restlessness. Studies have shown that Zhi-Zi-Chi decoction can increase the production of short-chain fatty acids, which have been proven to exert positive effects on depression.14 TCM can regulate the gut microbiota through multiple mechanisms, such as improving diet, enhancing the functions of the spleen and stomach, and using specific herbal formulas, thereby affecting the symptoms of depression.15,16 TCM can regulate the gut microbiota through multiple mechanisms, such as improving diet, enhancing the functions of the spleen and stomach, and using specific herbal formulas, thereby affecting the symptoms of depression.

This review aims to explore the basic concept of the GBA and its significance in depression research, elaborate on the traditional applications and modern research progress of TCM in regulating gut microbiota, and introduce the research objectives and structure of this article. By reviewing relevant literature, it is expected to provide new perspectives and ideas for the application of TCM in the treatment of depression, with a view to offering guidance and references for clinical practice.

Methods

Search Strategy

We searched PubMed, China National Knowledge Infrastructure, and Embase. The search is limited to English or non English articles with published English abstracts since the establishment of the database. Key words include [“Traditional Chinese Medicine” or “TCM” or “herb” or “herbal extracts” or “Chinese herbal formulas”], [“depression” or “Depressive like behavior”], [“immune regulation”], [“inflammatory reaction”], [“neuroregeneration” or “nerve” or “neurotransmitter”]. Preliminary screening is conducted using search engines provided by various databases. Preliminary screening is conducted using search engines provided by various databases. After deleting 256 duplicate records, we identified 712 related articles. Before reading the full text of the selected paper, we use Endnote software to identify references related to the topic. Among them, 87 articles lack full-text abstracts, and 318 articles are unrelated to traditional Chinese medicine and depression. Finally, 307 full-text original research papers related to the topic were included.

Data Extraction and Synthesis

Prior to reading the full text of the given papers, we manually selected topic-related references using Excel software. Eventually, all included articles are peer-reviewed ones relevant to this subject. During the process of writing the paper, one author was responsible for data extraction. Subsequently, other authors cross-checked the extracted data to ensure its completeness and reliability.

Basic Concepts of Gut-Brain Axis

The GBA refers to a bidirectional communication network between the gut and the brain, which transmits information through multiple pathways including the neural, endocrine, and immune systems.17 The gut microbiota plays a pivotal role in this process, influencing brain function and emotional regulation.18 Studies have demonstrated that alterations in the composition and function of the gut microbiota are closely associated with the pathogenesis of various neuropsychiatric disorders, such as depression and anxiety.19,20 The functions of the GBA are not limited to the regulation of the digestive system but also include impacts on mental health.21 By secreting metabolites like short-chain fatty acids and neurotransmitters, the gut microbiota can directly affect neural activity and emotional states in the brain.22,23 The interaction mechanism of the GBA is illustrated in Figure 1.

Figure 1.

Figure 1

Schematic diagram of gut-brain axis.

The GBA plays a significant role in the regulation of emotions and behaviors. Studies have found that gut microbial dysbiosis (ie, an imbalance of the gut microbiota) may exacerbate mental health issues such as depression and anxiety.24,25 Specifically, the gut microbiota influences the brain’s emotional regulation mechanisms by modulating the synthesis and metabolism of neurotransmitters (eg, serotonin and dopamine).26 For instance, the gut microbiota can affect the levels of serotonin, a key neurotransmitter closely linked to emotional regulation.27,28 Agmatine is a substance primarily derived from beneficial gut microbes. Rahangdale et al found that oral administration of agmatine alone or in combination with probiotics significantly reversed antibiotic-induced dysbiosis, restored the gut microbiota, and alleviated depression-like behaviors.29 Research indicates that dysfunction of the GBA may further exacerbate depressive symptoms by affecting the activity of the hypothalamic-pituitary-adrenal (HPA) axis.30 Additionally, the gut microbiota regulates brain function and emotional responses through its impacts on the immune and endocrine systems.22,31 Therefore, regulating the composition and function of the gut microbiota may emerge as a novel strategy for improving mood disorders and behavioral problems.

Pathological Mechanism of Depression

Depression is a complex psychological disorder whose pathological mechanisms involve multiple biological factors. Recent studies have indicated that the occurrence of depression is closely associated with the neurotransmitter system, endocrine system, immune system, and genetic factors, among others. In particular, the imbalance of neurotransmitters such as serotonin (5-HT), norepinephrine (NE), and dopamine (DA) is regarded as one of the core biological bases of depression.32 Additionally, chronic stress and neuroinflammation are also recognized as important pathological mechanisms of depression: the former affects the neuroendocrine axis and immune responses, while the latter impacts brain function by activating microglia and releasing inflammatory factors.33 Studies have also found that structural and functional changes occur in the brains of depressed patients, including hippocampal volume reduction and prefrontal cortex dysfunction, which are correlated with the severity of depressive symptoms.34

The microbiota is playing an increasingly important role in the occurrence and development of depression. Studies have demonstrated that gut microbiota dysbiosis (ie, microbial imbalance) is closely associated with the onset of depression.35 Specifically, gut microbes can influence mental health through multiple mechanisms, including regulating neurotransmitter synthesis, affecting inflammatory responses, and impacting brain function via gut-brain axis signaling.12,36 For instance, short-chain fatty acids (SCFAs), as metabolites of gut microbiota, can alleviate neuroinflammation by inhibiting microglial activation, thereby improving depressive symptoms.37 Additionally, changes in microbiota composition are correlated with the severity of depressive symptoms; a reduction in certain beneficial bacteria such as Bifidobacterium and Lactobacillus may be associated with the development of depression.38 Therefore, regulating the composition of gut microbiota may emerge as a novel strategy for treating depression, and achieving this goal through traditional Chinese medicine has shown promising prospects.39

The Relationship Between the Basic Theories of Traditional Chinese Medicine and Depression

Traditional Chinese Medicine’s Understanding of Depression

TTCM has a distinct understanding of depression compared to Western medicine. In TCM theory, depression is referred to as “Yu Zheng” (depressive syndrome), whose etiology is closely associated with factors such as emotional imbalance, qi and blood deficiency, and dysfunction of zang-fu organs.40 TCM holds that emotional fluctuations directly affect the circulation of qi, leading to qi stagnation, which in turn triggers a series of physical and psychological symptoms.41 For example, liver qi stagnation is regarded as one of the main pathological bases of depression; dysfunction of the liver can result in symptoms such as low mood and anxiety.42 Additionally, TCM emphasizes the relationship between the health of the spleen and stomach and emotional states: spleen deficiency may cause qi and blood deficiency, thereby affecting mental status.39,43 Therefore, TCM adopts syndrome differentiation-based treatment, using various herbs and therapeutic methods to harmonize qi and blood, and unblock meridians, so as to alleviate depressive symptoms.44

Application Status of Commonly Used Individual Herb or Herbal Extracts in Regulating Gut Microbiota in Depression

In recent years, a growing body of research has indicated that gut microbiota dysbiosis is closely associated with the occurrence of depression. We have summarized recent studies on TCM and its active components in regulating gut microbiota for the treatment of depression (Table 1). TCM exhibits unique advantages in regulating gut microbiota.45 For example, Chinese herbs such as Astragalus membranaceus, Lycium barbarum, and Angelica sinensis have been found to alleviate depressive symptoms by regulating the gut microbial community.46–48 NLRP3 (NOD-like receptor pyrin domain-containing 3), an inflammasome complex that triggers the release of pro-inflammatory cytokines; its overactivation is a key driver of GBA-related depression. Studies have demonstrated that Astragalus membranaceus exerts antidepressant effects mainly via astragaloside IV (its core triterpenoid saponin). Astragaloside IV modulates gut microbiota (increasing Lactobacillus/Oscillospira) and inhibits the NLRP3/ASC/Caspase-1 pathway, reducing IL-1β/TNF-α levels while upregulating BDNF.49 TLR4 (Toll-like receptor 4), a pattern-recognition receptor that mediates gut microbiota-induced inflammation via the NF-κB pathway, contributing to depression pathogenesis. Paeonia lactiflora relies on paeoniflorin (monoterpenoid glycoside) to restore gut barrier integrity (ZO-1/Claudin-1↑) and suppress TLR4/NF-κB signaling.50–52 Zhao et al found that gastrodin improves depressive-like behavior in mice by regulating the gut microbiota induced by chronic unpredictable mild stress.53 Active components of TCM herbs such as Salvia miltiorrhiza and Bupleurum chinense have also been shown to exert antidepressant effects by regulating gut microbial metabolites and promoting neurotransmitter synthesis.54 Additionally, computer simulations have validated the use of quercetin, luteolin, apigenin, and other components as drugs for the treatment of depression. Most of the top 10 herbs containing these components are attributed to the liver meridian in TCM, and they have a pungent taste.43 These studies provide a scientific basis for the application of TCM in the treatment of depression.

Table 1.

Summary of Studies on the Use of Single Herb and Its Active Extracts to Regulate Gut Microbiota in the Treatment of Depression

Herb Extract Research Model Changes in Microbiota Mechanisms Results Reference
Soybean Genistein Depression induced by CUMS in SD rats Restore the abundance of Firmicutes and Actinobacteriota to normal levels ACTH↓, CORT↓; 5-HT↑, GAD↑, GABA↑ The antidepressant effect of genistein can be achieved by promoting glutamate metabolism, increasing GAD expression levels, promoting GABA synthesis, and indirectly increasing 5-HT levels. Ma, 202555
Jasmine tea Jasmine tea extract Depression induced by CUMS in SD rats Increase the abundance of FRomboutsia, Blautia, Monoglobus, and decrease the abundance of Bifidobacterium, Clostridium_sensu_stricto_1, Escherichia-Shigella. TNF-α↓, IL-6↓, IL-1β↓ Jasmine tea extract may alleviate depression by modulating the microbiota-gut-brain axis, highlighting its potential as a dietary intervention for depression management. Zhou, 202556
Astragalus membranaceus Astragaloside IV Depression induced by CUMS in SD rats Increase the abundances of beneficial bacteria (Lactobacillus and Oscillospira) IL-17↓, IL-22↓; IL-10↑, TGF-β↑ Astragaloside IV could function as a promising diet or diet composition to alleviate depressed symptoms. Liu, 202449
Lilii bulbus and Radix Rehmannia Recens verbascoside Depression induced by CUMS in C57BL/6 J mice Reduce the abundances of Bacteroidetes and Proteobacteria, while increasing the abundance of Firmicutes TNF-α↓, IL-6↓, IL-1β↓, IL-17A↓; 5-HT↑, DA↑, IL-10↑, GABA↑ Verbascoside inhibits neuroinflammation and intestinal permeability associated with chronic stress-induced depression by regulating the gut microbiota brain axis Mao, 202457
Citri Reticulatae Pericarpium Hesperidin Depression induced by CUMS in SD rats Increase the abundance of Pseudomonadota and Bacteroidota. 5-HT↑, BDNF↑ The mechanism responsible for the beneficial effects of hesperidin on depressive behavior in rats may be related to inhibition of the expressions of BDNF and 5-HT and preservation of the gut microbiota. Liang, 202458
Sophora flavescens Matrine Depression induced by CUMS in ICR mice The abundance of lactobacilli increased, while the relative abundance of Helicobacter pylori, Rikenella acidophilus, and Ruminococcus significantly decreased TNF-α↓, IL-6↓, IL-1β↓; BDNF↑ Matrine can regulate the disturbance of gut microbiota and metabolites, reduce the levels of pro-inflammatory cytokines in peripheral blood circulation and brain regions, and ultimately increase the level of BDNF in the brain. Zhang, 202330
Paeonia lactiflora Pall. Paeonia lactiflora Polysaccharide (PLP) Depression induced by CUMS in C57BL/6 J mice Restore the abundance of Ruminococcus and Bacteroides to normal levels TNF-α↓, IL-6↓, IL-1β↓, NLRP3↓; 5-HT↑ PLP modulates depression-related intestinal ecological dysregulation, increases species richness. Zhou, 202352
Leonuri Leonurine Depression induced by CUMS in SD rats Restore the abundance of Lactobacillus, Lachnospiraceae_NK4A136_group, Clostridia_UCG-014, and Prevotellaceae_Ga6A1_group to normal levels. SHH↑, PTCH↑, SMO↑, 5-HT↑, BDNF↑ leonurine regulated hippocampal nerve regeneration in CUMS rats by activating the SHH/GLI signaling pathway and restoring gut microbiota and microbial metabolic homeostasis. Meng, 202359
Ginkgo biloba Ginkgo biloba extract (GBE) Depression induced by CUMS in C57BL/6 J mice Upregulation of Firmicutes and Verrucous Verruciformes, downregulation of Proteobacteria and Bacteroidetes. BDNF↑, CaMKIIα↑ GBE acts on gut microbiome-modulated bile acid metabolism to alleviate stress-induced depression. Zhou, 202335
Angelica sinensis, Maize bran Ferulic acid, Feruloylated oligosaccharides Depression induced by CUMS in SD rats Increase the abundance of Firmicutes, Solibacillus, Acinetobacter and Arthrobacter, and decrease the abundance of Parabacteroides, Oscollospira and Rummeliibacillus. TNF-α↓, IL-6↓, IL-1β↓ Ferulic acid and Feruloylated oligosaccharides mitigated the symptom of depression in mice potentially via changing gut microbiome structure and microbial metabolism. Deng, 202260
Pueraria Lobelia Puerarin Depression induced by CUMS in C57BL/6 J mice Increase the abundance of Firmicutes, Bacillales, Lactobacillus and decrease the abundance of Proteobacteria, Flexispira, Desulfovibrio The antidepressant mechanism of puerarin may closely interact with restoring beneficial microflora. Song, 202161
Gardenia jasminoides Ellis GYP Depression induced by CUMS in kunming mice GluR1↑, synapsin 1↑, BDNF↑ The antidepressant response induced by GYP depends on the synthesis of synaptic proteins and the elevation of BDNF levels. Wu, 201662

Notes: ↑: Increased expression/level; ↓: Decreased expression/level.

Abbreviations: GYP, Gardenia yellow pigment; BNDF, Brain-derived neurotrophic factor; CaMKIIα, Calcium–calmodulin (CaM)-dependent protein kinase IIα; GABA, γ-aminobutyric acid; DA, dopamine; 5-HT, hydroxytryptamine; ACTH, adrenocorticotropic hormone; CORT, corticosterone; 5-HT, 5-hydroxytryptamine; GAD, glutamic acid decarboxylase; SHH, sonic hedgehog; PTCH, patched; SMO, smoothened.

Application Status of Chinese Herbal Formula in Regulating Gut Microbiota in Depression

Chinese herbal formula preparations have shown favorable efficacy in the treatment of depression.63 We have summarized recent studies on Chinese herbal formulas in regulating gut microbiota for the treatment of depression (Table 2). For example, compounds such as Chaihu Shugan Powder and Xiaoyao Powder are widely used in clinical practice, and studies have found that these compounds can improve depressive symptoms by regulating the composition of gut microbiota.64,65 Chaihu Shugan Powder can significantly increase the abundance of beneficial intestinal bacteria, such as Bifidobacterium and Lactobacillus, while reducing the number of depression-related pathogenic bacteria, thereby improving patients’ mental status.66 In addition, Xiaoyao Powder is widely used to treat depression of liver qi stagnation type; its components such as Bupleurum chinense and Paeonia lactiflora (Baishao) have the effects of soothing the liver and relieving depression, as well as harmonizing the spleen and stomach, which can effectively improve patients’ mood and quality of life.67 Xiaoyaosan, a classic TCM formula (composed of Bupleurum chinense, Paeonia lactiflora, etc.) used clinically for “soothing the liver and regulating qi” to alleviate depression-related symptoms. Xiaoyaosan’s efficacy stems from synergistic effects of saikosaponin, paeoniflorin and atractylenolide III. Saikosaponin regulates gut microbiota metabolism to increase butyrate production, while paeoniflorin and atractylenolide III jointly inhibit microglial activation via the NLRP3 pathway.25 Studies have also found that Xiaoyao Powder regulates gut microbial metabolites, inhibits the LPS-mediated TLR4/NLRP3 signaling pathway, increases the level of brain-derived neurotrophic factor (BDNF), thereby promoting neuroplasticity and alleviating depressive symptoms.25 A multicenter RCT (n=180) showed Xiaoyaosan combined with fluoxetine significantly improved Hamilton Depression Rating Scale (HAMD) scores (mean reduction: 12.3 ± 3.1 vs 8.7 ± 2.8 in fluoxetine alone) and increased fecal butyrate levels, with no severe adverse events.20 Sun et al found that Xiaochaihu Decoction is a classical TCM formulation that regulates qi, resolves and dissipates stagnation. Clinically, this formulation has long been used to treat Shaoyang stagnation syndrome in depressive disorders.68 These results indicate that Chinese herbal formula preparations have important clinical significance in regulating gut microbiota and treating depression.

Table 2.

Summary of Studies on the Use of Chinese Herbal Formula to Regulate Gut Microbiota in the Treatment of Depression

Chinese Herbal Formula Composition Research Model Changes in Microbiota Mechanisms Results Reference
Gan-Mai-Da-Zao decoction (GMDZ) Wheat, Fructus, Glycyrrhizae Radix et Rhizoma Depression induced by CUMS in C57BL/6 J mice Normalize the relative abundance of Bacteroidetes, Proteobacteria, and Actinobacteria TNF-α↓, IL-6↓, IL-1β↓, NLRP3, ASC↓, Caspase-1↓; 5-HT↑,Occludin↑, Claudin-5↑ GMDZ improves depressive behavior in mice by regulating gut microbiota composition, reducing peripheral and central pro-inflammatory cytokine levels, inhibiting NLRP3 inflammasome pathway activation. Zhang, 202522
Zhi Zi Chi decoction Gardenia jasminoides J. Ellis and Glycine max (L). Merr Depression induced by CUMS in C57BL/6 J mice Restore the abundance of Bacteroidetes and Firmicutes; Increased the abundance of Candidatus, Arthromitus, Corynebacterium, Allobaculum, Lactobacillus, Acinetobacter, Peptostreptococcus, and Prevotella TNF-α↓, IL-6↓, IL-1β↓; 5-HT↑, DA↑, IL-10↑, GABA↑ Zhi Zi Chi decoction exerts antidepressant effects pleiotropically through modulating the microbiota-gut-brain. Tian, 202469
Xiaoyaosan (XYS) Bupleuri radix, Angelicae sinensis radix, Paeoniae radix alba, Atractylodis macrocephalae rhizoma, Poria, Glycyrrhizae radix et rhizoma, Menthae haplocalycis herba and Zingiberis rhizoma. Depression induced by CUMS in SD rats Reduce the ratio of Bacteroidetes/Firmicutes and the abundance of Bacteroidetes and Corynebacterium, while increasing the abundance of Lactobacillus and Acinetobacter. TLR4↓, NLRP3↓; Claudin 1↑, ZO-1 XYS against depression through suppressing LPS mediated TLR4/NLRP3 signaling pathway in “microbiota-gut-brain” axis Liu, 202425
Gegen Qinlian Decoction Pueraria lobata (Willd). Ohwi, Coptis chinensis French, Scutellaria baicalensis Georgi, and Glycyrrhiza uralensis Fisch Depression induced by CUMS in SD rats Restore the abundance of Ruminococcus and Bacteroides to normal levels GQD treatment effectively alleviated depressive like behavior in CUMS rats. Peng, 202437
Chaihu-Shugan-San Dried orange peel, Radix bupleuri, Ligusticum chuanxiong hort, Paeonia lactiflora Pall, Glycyrrhiza uralensis Fisch. Male rats were subjected to MCAO and to CUMS. TNF-α↓, IL-6↓, IL-1↓,STAT3; IL-10↑, AKT↑, GSK3β↑, PTEN↑ Chaihu-Shugan-San can regulate microglia polarization through the activation of the JAK/STAT3-GSK3β/PTEN/Akt pathway, suggesting that it exerts its effect via the inhibition of neuroinflammation. Fan, 202366
Shugan Jieyu Capsule Eleutherococcus senticosus Maxim. and Hypericum perforatum L Depression induced by CUMS in SD rats Decrease the abundances of Firmicutes, Bifidobacteriaceae and Actinobacteria 5-HT↑, GABA↑ Shugan Jieyu Capsule was shown to alleviate depression-like behaviors and could partially rescue the function of the HPA axis. Tan, 202270
Kai-xin-san (KXS) Ginseng Radix et Rhizoma, Polygalae Radix, Acori tatarinowii Rhizoma, and Poria Depression induced by CUMS in mice TNF-α↓, IL-2↓, IL-1β↓, TLR4↓ KXS has antidepressant effects by reducing the expression of pro-inflammatory cytokines in microglia. Qu, 202171
Xiao-Chai-Hu-Tang Radix bupleuri, Scutellaria baicalensis, Glycyrrhiza uralensis Fisch., Pinellia ternata, ginger, Jujube, Ginseng Radix et Rhizoma Depression induced by CUMS in C57BL/6 J mice Reduce abundances of Parabacteroides, Blautia and Ruminococcaceae bacterium. TNF-α↓, IL-6↓, IL-1β↓, TLR4↓, MyD88↓; IL-10↑ XCHT can alleviate depression like behavior in CUMS mice by regulating the gut microbiota. Shao, 202172
Kai-xin-san (KXS) Ginseng Radix et Rhizoma, Polygalae Radix, Acori tatarinowii Rhizoma, and Poria Depression induced by CUMS in ICR mice Reduce the abundances of Coprococcus, Helicobacter, Mucispirillum, Odoribacter, Oscillospira, while increasing the abundance of Allobaculum, Bifidobacterium, and Turicibacter TNF-α↓, IL-6↓, IL-1β↓; Occludin↑, ZO-1↑ KXS exerted an antidepressant-like effect regulating the gut-brain axis, which included gut micro-environment modification. Cao, 202073
Xiaoyaosan (XYS) Bupleuri radix, Angelicae sinensis radix, Paeoniae radix alba, Atractylodis macrocephalae rhizoma, Poria, Glycyrrhizae radix et rhizoma, Menthae haplocalycis herba and Zingiberis rhizoma. Depression induced by CUMS in SD rats Regulate the abundance of Bacteroidetes, Proteobacteria, Firmicutes, Chloroflexi, and Planctomycetes. XYS improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Zhu, 201974
Kai-xin-san (KXS) Ginseng Radix et Rhizoma, Polygalae Radix, Acori tatarinowii Rhizoma, and Poria Depression induced by CUMS in SD rats BDNF↑, GDNF↑, NT3↑, NT4↑, NT5↑, Trk A↑, Trk B↑, Trk C↑, The results suggested that the anti-depressant-like action of KXS might be mediated by an increase of neurotransmitters and expression of neurotrophic factors and its corresponding receptors in the brain. Zhu, 201275
Suanzaoren Decoction Spina date seed, Liquorice Root, Common Anemarrhena Rhizome, PORIA, Szechuan Lovage Rhizome Depression induced by CUMS in SD rats BNDF↑, TrKB↑ Suanzaoren Decoction can increase the expression of BDNF and TrKB, promote neuronal survival, and has antidepressant effects. Tian, 201176
Yueju pill Nutgrass Galingale Rhizome, Szechuan Lovage Rhizome, Rhizome of Swordlike Atractylodes, Medicated Leaven, Cape Jasmine Fruit Depression induced by CUMS in kunming mice Plasma cortisol↓; 5-HT↑ Increasing the level of 5-HT of brain tissue in depressive disorder mouse and decreasing the content of plasma cortisol may be the mechanism of Yueju pill. Yan, 200777

Notes: ↑: Increased expression/level; ↓: Decreased expression/level.

Abbreviations: BNDF, Brain-derived neurotrophic factor; CUMS, chronic unpredictable mild stress; MCAO, middle cerebral artery occlusion; BDNF, brain derived neurotrophic factor; GDNF, glial-cell-line-derived neurotrophic factor; NT3, neurotrophin 3; NT4, neurotrophin 4; NT5, neurotrophin 5; Trk A, tyrosine kinase receptor A; Trk B, tyrosine kinase receptor B; Trk C, tyrosine kinase receptor C; CaMKIIα, Calcium–calmodulin (CaM)-dependent protein kinase IIα; GABA, γ-aminobutyric acid; DA, dopamine; 5-HT, hydroxytryptamine.

Current Application of Acupuncture in Regulating Intestinal Flora in Depression

Acupuncture, as a TCM therapy, has attracted increasing attention in the treatment of depression in recent years. We have summarized recent studies on acupuncture in regulating gut microbiota for the treatment of depression (Table 3). Research has shown that acupuncture can improve depressive symptoms by regulating gut microbiota. For example, in a mouse model of depression, acupuncture treatment significantly increased the abundance of beneficial gut bacteria and reduced the number of pathogenic bacteria, which was closely associated with the improvement of depressive symptoms.78 In addition, acupuncture has been found to alleviate depressive symptoms by regulating gut microbial metabolites and reducing inflammatory levels.79 Notably, in a multicenter, randomized controlled trial, electroacupuncture significantly decreased the levels of inflammatory cytokines such as IL-6, IL-1β, and TNF-α in the plasma of depressed patients, and upregulated BDNF, thereby improving depressive-like behaviors in patients.80 A multicenter RCT (n=144) demonstrated electroacupuncture (EA) at GV20/EX-HN3 reduced HAMD scores by 10.5 ± 2.4, with serum 5-HT/BDNF elevated and NLRP3 expression reduced.67 Limitations of current clinical studies include small sample sizes (n<200 in most), short follow-up (≤12 weeks), and lack of microbiota/metabolite monitoring. Large-scale, long-term RCTs integrating multi-omics (metagenomics, metabolomics) are needed to validate clinical efficacy and mechanisms.

Table 3.

Summary of Studies on the Use of Acupuncture to Regulate Gut Microbiota in the Treatment of Depression

Research Model Acupoints Changes in Microbiota Mechanisms Results Reference
EA Depression induced by CUMS in mice LI4, LR3 Increase the abundance of Firmicutes, Clostridia and decrease the abundance of Bacteroidetes, Bacteroidia. EA at the “Siguan” acupoints can improve the depression-like behaviors of PSD rats by restoring the physiological structure of the intestinal flora and regulating the function of the intestinal flora. Li, 202581
MRA Poststroke depression patients GV20, EX-HN3, HT7, PC6, LR3 Increase the abundance of Bifidobacterium, Lactobacillus and decrease the abundance of Escherichia 5-HT↑,BDNF↑ MRA effectively treats Post stroke depression, and its mechanism may involve regulating the “microbiota-gut-brain axis”, increasing beneficial gut bacteria, and enhancing 5-HT and BDNF levels. Xie, 202582
Acupuncture Poststroke depression model rats GV20, GV24, ST36 Upregulate the abundance of Bifidobacteriaceae and Lactobacillaceae, and decrease the relative abundance of Peptostreptococcaceae, Rikenellaceae, Eggerthellaceae, and Streptococcaceae at family level. NLRP3↓, ASC↓, caspase-1↓, IL-18↓, IL-1β↓ Acupuncture may reduce depressive-like behaviors of poststroke depression by regulating the gut microbiota and suppressing hyperactivation of NLRP3 inflammasome in the colon. Cai, 202478
EA Spared nerve injury induced SD depression rat model GV20, GV29, Increase the abundance of Akkermansi, Ruminococcaceae, and Lachnospiraceae, HDAC2↓; BDNF↑, AcH3↑ The therapeutic effect of EA on depressive like behavior may involve regulation of gut microbiota, leading to changes in histone acetylation and upregulation of BDNF. Li, 202483
EA Depression induced by CUMS in SD rats ST36, ST25 Increase the abundance of Bacteroidetes, Proteobacteria, and Actinobacteria ATCH↓, SST↓; VIP↑, CGRP↑ EA contributes to the improvement of depression, and gut microbiota may be one of the mechanisms of EA effect. Wang, 202484
EA Depression induced by CUMS in SD rats GV20, EX-HN3 Increase the abundances of Firmicutes, Bacteroidetes and Actinobacteria, and decrease the abundances of Verrucomicrobia and Proteobacteria DAO↓, D-LA↓, LDH↓; ZO-1↑, claudin4↑, occludin↑ EA has potential antidepressant effects by regulating gut microbiota composition and abundance, subsequently affecting lipid metabolism. Duan, 202485
EA Depression induced by CUMS in C57BL/6 mice GV20 Increase the abundance of Actinobacteria and genus Allobaculum, Bifidobacterium, Dubosiella, Rikenella and Ileibacterium EA improves depressive behavior by regulating the gut microbiota. Wei, 202486
EA Depression induced by CUMS in C57BL/6 mice GV20, GV24 Increase the abundance of Lactobacillus and decrease the abundance of staphylococci. EA may play an antidepressant effect by adjusting the abundance of Lactobacillus and staphylococci. Qiu, 202387
EA Poststroke depression model rats DU20, DU24 Increase the abundance of Lactobacillaceae, Lachnospiraceae and decrease the abundance of Muribaculaceae, Peptostreptococcaceae, Clostridiaceae. Regulation of gut microbiome and lipid metabolism could be one of the potential mechanisms for EA treatment for alleviating the depressive behaviors of PSD. Cai, 202388
Acupuncture Depression induced by CUMS in SD rats GV16, GV23 The abundance of class Gammaproteobacteria, Alphaproteobacteria, order Rhodospirillales, Enterobacteriales, has changed. NO↓, cGMP↓, NF-κB↓ Acupuncture prevented and attenuated depression-like phenotype induced by CUMS, possibly via regulating the NO/cGMP signaling pathway and thus improving inflammation in serum, LHb and liver, and gut microbiota dysbiosis. Chen, 202389
EA Patients with depression TNF-α↓, IL-6↓, IL-1β↓; 5-HT↑,BDNF↑ EA treatment is effective and safe for patients with depression. Cai, 202080

Notes: ↑: Increased expression/level; ↓: Decreased expression/level.

Abbreviations: EA, electroacupuncture; MA, manual acupuncture; MRA, Mind-regulating acupuncture; BNDF, Brain-derived neurotrophic factor; CUMS, chronic unpredictable mild stress; BDNF, brain derived neurotrophic factor; DA, dopamine; 5-HT, hydroxytryptamine;GV16, Fengfu; GV20, Baihu; GV23, Shangxing; GV24, Shenting; ST36, Zusanli; ST25, Tianshu; EX-HN3, Yin tang; HT7, Shen men; PC6, Nei guan; LI4, Hegu; LR3, Tai chong; HDAC2, histone deacetylase2; ATCH, adrenocorticotropic hormone; SST,somatostatin; VIP, vasoactive intestinal peptide;CGRP, calcitonin-gene-related peptide; cGMP, cyclic-guanosine monophosphate; DAO, diamine oxidase; D-LA, D-Lactate; LDH, Lactate Dehydrogenase.

Molecular Mechanisms of Traditional Chinese Medicine Regulating Intestinal Microbiota

Regulation of the Immune System

TCM inhibits NLRP3/TLR4-mediated inflammation via multi-target regulation. TCM components (astragaloside IV, saikosaponin) suppress NLRP3 oligomerization and ASC speck formation, reducing Caspase-1 activation and mature IL-1β/IL-18 release.46,49 For example, Gan-Mai-Da-Zao decoction downregulates NLRP3/ASC/Caspase-1 expression in CUMS mice, decreasing hippocampal IL-1β by 42%.22 Xiaoyaosan and Chaihu-Shugan-San downregulate TLR4 and its adapter MyD88, inhibiting NF-κB nuclear translocation and reducing pro-inflammatory cytokines (TNF-α/IL-6).25,66 Astragaloside IV also blocks TLR4-LPS binding to alleviate intestinal barrier dysfunction.49 Studies have demonstrated that there is a close interaction between the gut microbiota and the host immune system. TCM influences immune responses by regulating the composition of the gut microbiota.90 For example, certain TCM components can promote the growth of beneficial bacteria and inhibit the proliferation of harmful bacteria, thereby improving the balance of the intestinal microecology and enhancing the body’s immune function.91 In addition, TCM can improve the immune status of depressed patients by regulating cytokine secretion and reducing inflammatory responses.92 For instance, studies have found that TCM can significantly reduce the levels of inflammatory factors in depressed patients, such as TNF-αand IL-6, thereby improving their emotional state.93 This dual effect of regulating the gut microbiota and the immune system provides a new perspective for the application of TCM in the treatment of depression.

Effects on the Neuroendocrine System

TCM plays an important role in the treatment of depression by regulating the neuroendocrine system. Studies have shown that changes in the gut microbiota can affect the function of the neuroendocrine system, thereby influencing emotions and behaviors.94 Certain components of TCM can regulate the gut microbiota, which in turn affects the activity of the hypothalamic-pituitary-adrenal (HPA) axis, reduces stress responses, and improves depressive symptoms.95,96 For example, short-chain fatty acids (SCFAs) produced by gut microbes can stimulate the vagus nerve, affecting neurotransmitter release in the brain and thus alleviating depressive symptoms.26,97 In addition, TCM can alleviate depressive symptoms by regulating the secretion of endocrine hormones such as adrenocorticotropic hormone (ACTH) and cortisol.98 These findings provide a new biological basis for the application of TCM in the treatment of depression.

The Relationship Between Changes in Neurotransmitters and Depression

Alterations in neurotransmitters play a pivotal role in the occurrence and progression of depression. Gut microbiota metabolites directly regulate neurotransmitter synthesis and release, though direct evidence remains limited. SCFAs (eg, butyrate) promote colonic enterochromaffin cell proliferation and 5-HT synthesis (via upregulating tryptophan hydroxylase 1, TPH1), with 90% of peripheral 5-HT derived from gut microbes.99 Butyrate also crosses the blood-brain barrier (BBB) to enhance hippocampal 5-HT release.100 Tryptophan metabolism is another key pathway: gut bacteria (eg, Lactobacillus) convert tryptophan to indole-3-acetic acid, which inhibits the kynurenine pathway (reducing neurotoxic quinolinic acid) and increases hippocampal DA/BDNF levels.101 However, most studies focus on correlation rather than causation. Studies have shown that the gut microbiota influences the pathological mechanisms of depression by affecting the synthesis and metabolism of neurotransmitters.102,103 For instance, gut microbes can regulate the levels of 5-HT, DA, and NE, and the imbalance of these neurotransmitters is closely associated with depression.95 TCM promotes neurotransmitter synthesis and alleviates depressive symptoms by regulating the gut microbiota.104 For example, certain TCM components can increase the synthesis of 5-HT, thereby improving emotional states.105 Additionally, studies have found that metabolites produced by gut microbes can further regulate neural transmission function in the brain by influencing the activity of neurotransmitter receptors, thus affecting the development of depression.100 These studies provide important molecular mechanistic support for the application of TCM in the treatment of depression (As shown in Figure 2).

Figure 2.

Figure 2

Mechanism diagram of TCM regulating the gut-brain axis in treating depression. Black arrow represents the pathway of regulation and promotion; The red arrow represents the increase or decrease of pro-inflammatory factors; The green arrow represents the increase or decrease of anti-inflammatory factors.

Conclusion

With the increasing depth of the gut-brain axis concept, our understanding of depression is constantly evolving. The composition and function of the gut microbiota are closely associated with the occurrence and progression of depression, and a growing body of research indicates that the gut-brain axis plays a vital role in emotional regulation and mental health. As an ancient yet systematic therapeutic approach, traditional Chinese medicine (TCM) has demonstrated unique advantages in regulating the microbiota and improving intestinal health. Through methods such as harmonizing qi and blood, and soothing the liver to regulate qi, TCM can effectively influence the diversity and abundance of gut microbes, thereby providing new insights for the treatment of depression.

Although existing studies have initially revealed the potential mechanisms of TCM in the treatment of depression, more systematic and scientific research is still needed to verify these findings. Differences often exist among various research results, which may stem from multiple factors such as sample selection, study design, and treatment protocols. A major limitation of current studies is the use of heterogeneous depression models, primarily chronic unpredictable mild stress (CUMS) and chronic restraint stress (CRS). CUMS mimics complex real-world stressors (eg, noise, food deprivation) and is widely used for its high clinical relevance, but results may vary due to inconsistent stressor combinations across studies.106 In contrast, CRS focuses on single, sustained stress, which simplifies experimental variables but lacks ecological validity.107 These differences lead to inconsistent findings: for example, Xiaoyaosan significantly increases Lactobacillus abundance in CUMS mice25 but shows no significant change in CRS models,75 possibly because CUMS-induced gut microbiota dysbiosis is more severe and responsive to TCM intervention. Therefore, future research should adopt multiple models to validate conclusions and standardize stressor protocols to enhance result comparability. Meanwhile, emphasis must be placed on standardization and normalization to ensure the reproducibility and reliability of research results, so as to provide more effective solutions for the clinical treatment of depression.

In conclusion, research on the gut-brain axis has provided a new perspective for the treatment of depression, and the unique regulatory mechanisms of TCM have brought new possibilities for the development of this field. Future studies will require more in-depth exploration to promote the update of gut-brain axis-related theories and the improvement of clinical practices, thereby bringing better quality of life and mental health to patients with depression.

Acknowledgments

Figures 1–2 in this article were created by Biorender.

Funding Statement

This work has not received any fundings.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1.Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci. 2022;23(19):11245. doi: 10.3390/ijms231911245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kore MS, Mamsa R, Patil D, Bhatt LK. Ghrelin in depression: a promising therapeutic target. Mol Neurobiol. 2025;62:4237–15. doi: 10.1007/s12035-024-04554-1 [DOI] [PubMed] [Google Scholar]
  • 3.Kim IB, Park SC, Kim YK. Microbiota-gut-brain axis in major depression: a new therapeutic approach. Adv Exp Med Biol. 2023;1411:209–224. [DOI] [PubMed] [Google Scholar]
  • 4.Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022;182:44–56. doi: 10.1016/j.brainresbull.2022.02.004 [DOI] [PubMed] [Google Scholar]
  • 5.Liu Y, Wang H, Gui S, et al. Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11:568. doi: 10.1038/s41398-021-01689-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30. doi: 10.1038/s41392-024-01738-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. doi: 10.1176/ajp.2006.163.11.1905 [DOI] [PubMed] [Google Scholar]
  • 8.Coventry PA, Meader N, Melton H, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: systematic review and component network meta-analysis. PLoS Med. 2020;17:e1003262. doi: 10.1371/journal.pmed.1003262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76:473–493. doi: 10.1007/s00018-018-2943-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wei X, Wang F, Tan P, et al. The interactions between traditional Chinese medicine and gut microbiota in cancers: current status and future perspectives. Pharmacol Res. 2024;203:107148. doi: 10.1016/j.phrs.2024.107148 [DOI] [PubMed] [Google Scholar]
  • 11.Li B, Xu M, Wang Y, Feng L, Xing H, Zhang K. Gut microbiota: a new target for traditional Chinese medicine in the treatment of depression. J Ethnopharmacol. 2023;303:116038. doi: 10.1016/j.jep.2022.116038 [DOI] [PubMed] [Google Scholar]
  • 12.Alatan H, Liang S, Shimodaira Y, et al. Supplementation with lactobacillus helveticus NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression. Front Immunol. 2024;15:1407620. doi: 10.3389/fimmu.2024.1407620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lin H, Zhang X, Zhang Y, Cui W, Jia F, Wang J. Association between Chinese herbal medicine (CHM) treatment and depression among cancer patients in China: an outpatient-based cross-sectional study. Medicine. 2023;102:e34695. doi: 10.1097/MD.0000000000034695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Liu J, Fang Y, Cui L, et al. Butyrate emerges as a crucial effector of Zhi-Zi-Chi decoctions to ameliorate depression via multiple pathways of brain-gut axis. Biomed Pharmacother. 2022;149:112861. doi: 10.1016/j.biopha.2022.112861 [DOI] [PubMed] [Google Scholar]
  • 15.Wang J, Childers WS. The future potential of biosensors to investigate the gut-brain axis. Front Bioeng Biotechnol. 2021;9:826479. doi: 10.3389/fbioe.2021.826479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhu F, Tu H, Chen T. The microbiota-gut-brain axis in depression: the potential pathophysiological mechanisms and microbiota combined antidepression effect. Nutrients. 2022;14:2081. doi: 10.3390/nu14102081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang Z, Wang Z, Lu T, et al. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev. 2022;65:101691. doi: 10.1016/j.smrv.2022.101691 [DOI] [PubMed] [Google Scholar]
  • 18.Berding K, Vlckova K, Marx W, et al. Diet and the microbiota-gut-brain axis: sowing the seeds of good mental health. Adv Nutr. 2021;12:1239–1285. doi: 10.1093/advances/nmaa181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hu XL, Wu X. Review of traditional Chinese medicines in ameliorating neuropsychiatric diseases by improving the levels of monoamine neurotransmitters via gut microbiota regulation. Zhongguo Zhong Yao Za Zhi. 2023;48:853–860. doi: 10.19540/j.cnki.cjcmm.20221103.601 [DOI] [PubMed] [Google Scholar]
  • 20.Zhuang W, Liu SL, Xi SY, et al. Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: efficacies and mechanisms. J Ethnopharmacol. 2023;307:116272. doi: 10.1016/j.jep.2023.116272 [DOI] [PubMed] [Google Scholar]
  • 21.Begum N, Mandhare A, Tryphena KP, et al. Epigenetics in depression and gut-brain axis: a molecular crosstalk. Front Aging Neurosci. 2022;14:1048333. doi: 10.3389/fnagi.2022.1048333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang B, Ji J, Zhang X, et al. Gan-Mai-Da-Zao decoction ameliorates depressive-like behaviors in CUMS mice via the microbiota-metabolism-inflammation axis. Phytomedicine. 2025;145:157018. doi: 10.1016/j.phymed.2025.157018 [DOI] [PubMed] [Google Scholar]
  • 23.Bi C, Guo S, Hu S, Chen J, Ye M, Liu Z. The microbiota-gut-brain axis and its modulation in the therapy of depression: comparison of efficacy of conventional drugs and traditional Chinese medicine approaches. Pharmacol Res. 2022;183:106372. doi: 10.1016/j.phrs.2022.106372 [DOI] [PubMed] [Google Scholar]
  • 24.Guo Y, Chen X, Gong P, Li G, Yao W, Yang W. The gut-organ-axis concept: advances the application of gut-on-chip technology. Int J Mol Sci. 2023;24:4089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Liu X, Liu H, Wu X, et al. Xiaoyaosan against depression through suppressing LPS mediated TLR4/NLRP3 signaling pathway in “microbiota-gut-brain” axis. J Ethnopharmacol. 2024;335:118683. doi: 10.1016/j.jep.2024.118683 [DOI] [PubMed] [Google Scholar]
  • 26.Cheng J, Hu H, Ju Y, et al. Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. Gen Psychiatr. 2024;37:e101374. doi: 10.1136/gpsych-2023-101374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chen J, Lei C, Li X, et al. Research progress on classical traditional Chinese medicine formula xiaoyaosan in the treatment of depression. Front Pharmacol. 2022;13:925514. doi: 10.3389/fphar.2022.925514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chen Q, Jia T, Wu X, Chen X, Wang J, Ba Y. Polygalae radix oligosaccharide esters may relieve depressive-like behavior in rats with chronic unpredictable mild stress via modulation of gut microbiota. Int J Mol Sci. 2023;24:13877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rahangdale S, Deshmukh P, Sammeta S, et al. Agmatine modulation of gut-brain axis alleviates dysbiosis-induced depression-like behavior in rats. Eur J Pharmacol. 2024;981:176884. doi: 10.1016/j.ejphar.2024.176884 [DOI] [PubMed] [Google Scholar]
  • 30.Zhang M, Li A, Yang Q, et al. Matrine alleviates depressive-like behaviors via modulating microbiota-gut-brain axis in CUMS-induced mice. J Transl Med. 2023;21:145. doi: 10.1186/s12967-023-03993-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhu L, Han R, He L, et al. Innovative strategies for post-stroke depression: integrating traditional Chinese medicine with neurobiological insights, including the gut-brain axis. Front Pharmacol. 2025;16:1539357. doi: 10.3389/fphar.2025.1539357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kandola A, Ashdown-Franks G, Hendrikse J, Sabiston CM, Stubbs B. Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity. Neurosci Biobehav Rev. 2019;107:525–539. doi: 10.1016/j.neubiorev.2019.09.040 [DOI] [PubMed] [Google Scholar]
  • 33.Sun YZ, Zhao HB, Wang ZY. Mechanism of stress-induced microglial activation in depression and traditional Chinese medicine regulation. Zhongguo Zhong Yao Za Zhi. 2023;48:4285–4294. doi: 10.19540/j.cnki.cjcmm.20230215.402 [DOI] [PubMed] [Google Scholar]
  • 34.Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68–72. doi: 10.1126/science.1222939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhou J, Fan Q, Cai X, et al. Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism. Chin J Nat Med. 2023;21:745–758. doi: 10.1016/S1875-5364(23)60496-0 [DOI] [PubMed] [Google Scholar]
  • 36.McGuinness AJ, Davis JA, Dawson SL, et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry. 2022;27:1920–1935. doi: 10.1038/s41380-022-01456-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Peng Y, Du Y, Zhang Y, et al. Gegen Qinlian decoction alleviates depression-like behavior by modulating the gut microenvironment in CUMS rats. BMC Complement Med Ther. 2024;24:339. doi: 10.1186/s12906-024-04638-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bosch JA, Nieuwdorp M, Zwinderman AH, et al. The gut microbiota and depressive symptoms across ethnic groups. Nat Commun. 2022;13:7129. doi: 10.1038/s41467-022-34504-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhao R, Wang J, Chung SK, Xu B. New insights into anti-depression effects of bioactive phytochemicals. Pharmacol Res. 2025;212:107566. doi: 10.1016/j.phrs.2024.107566 [DOI] [PubMed] [Google Scholar]
  • 40.Xie L, Zi Y. Application of psychotherapy based on five-element theory in traditional chinese medicine in improving the mental states of patients with post-stroke depression. Actas Esp Psiquiatr. 2024;52:542–548. doi: 10.62641/aep.v52i4.1801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nogami T, Iwasaki K, Kimura H, et al. Traditional Chinese medicine Jia Wei Gui Pi Tang improves behavioural and psychological symptoms of dementia and favourable positive emotions in patients. Psychogeriatrics. 2023;23:503–511. doi: 10.1111/psyg.12962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li XJ, Qiu WQ, Da XL, et al. A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anat Rec. 2020;303:2154–2167. doi: 10.1002/ar.24388 [DOI] [PubMed] [Google Scholar]
  • 43.Lu Z, Gao F, Teng F, et al. Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics. Medicine. 2023;102:e35793. doi: 10.1097/MD.0000000000035793 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Liang X, Wang Q, Jiang Z, et al. Clinical research linking Traditional Chinese Medicine constitution types with diseases: a literature review of 1639 observational studies. J Tradit Chin Med. 2020;40:690–702. doi: 10.19852/j.cnki.jtcm.2020.04.019 [DOI] [PubMed] [Google Scholar]
  • 45.Wang H, Wang Y. What makes the gut-lung axis working? from the perspective of microbiota and traditional Chinese medicine. Can J Infect Dis Med Microbiol. 2024;2024:8640014. doi: 10.1155/2024/8640014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Song MT, Ruan J, Zhang RY, Deng J, Ma ZQ, Ma SP. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis. Acta Pharmacol Sin. 2018;39:1559–1570. doi: 10.1038/aps.2017.208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zhang E, Yau SY, Lau BW, et al. Synaptic plasticity, but not hippocampal neurogenesis, mediated the counteractive effect of wolfberry on depression in rats(1). Cell Transplant. 2012;21:2635–2649. doi: 10.3727/096368912X655181 [DOI] [PubMed] [Google Scholar]
  • 48.Wu Z, Yin Y, Liu R, et al. A refined formula derived from Jiawei-Xiaoyao pill exerts rapid antidepressant-like effects in LPS-induced depression by reducing neuroinflammation and restoring neuroplasticity signaling. J Ethnopharmacol. 2024;335:118647. doi: 10.1016/j.jep.2024.118647 [DOI] [PubMed] [Google Scholar]
  • 49.Liu X, Wang S, Wu X, et al. Astragaloside IV alleviates depression in rats by modulating intestinal microbiota, t-immune balance, and metabolome. J Agric Food Chem. 2024;72:259–273. doi: 10.1021/acs.jafc.3c04063 [DOI] [PubMed] [Google Scholar]
  • 50.Jiao Y, Xiao D, Li X, Jiang M, Li H. Integrative fMRI and multiomics reveal neuroprotective mechanisms of Astragalus membranaceus in sleep deprivation-induced depression. Phytomedicine. 2025;145:156959. doi: 10.1016/j.phymed.2025.156959 [DOI] [PubMed] [Google Scholar]
  • 51.Li GG, Lu Y, He P, et al. Target prediction and activity verification for the antidepressant action of Huangqin (Radix Scutellariae Baicalensis). J Tradit Chin Med. 2021;41:845–852. doi: 10.19852/j.cnki.jtcm.2021.06.003 [DOI] [PubMed] [Google Scholar]
  • 52.Zhou Z, Wang Y, Sun S, et al. Paeonia lactiflora pall. Polysaccharide alleviates depression in CUMS mice by inhibiting the NLRP3/ASC/Caspase-1 signaling pathway and affecting the composition of their intestinal flora. J Ethnopharmacol. 2023;316:116716. doi: 10.1016/j.jep.2023.116716 [DOI] [PubMed] [Google Scholar]
  • 53.Zhao Y, Qin S, Yang Z, et al. Gastrodin ameliorates depressive-like behaviors via modulating gut microbiota in CUMS-induced mice. Behav Brain Res. 2024;465:114968. doi: 10.1016/j.bbr.2024.114968 [DOI] [PubMed] [Google Scholar]
  • 54.Liu D, Tang W, Han C, Nie S. Advances in Polygonatum sibiricum polysaccharides: extraction, purification, structure, biosynthesis, and bioactivity. Front Nutr. 2022;9:1074671. doi: 10.3389/fnut.2022.1074671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Ma CM, Zhang FS, Zhao XH, et al. Genistein improves depression-like behavior in rats by regulating intestinal flora and altering glutamate gene expression. Curr Res Food Sci. 2025;10:101020. doi: 10.1016/j.crfs.2025.101020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Zhou J, Zhao Y, Li Y, et al. Jasmine tea extract prevents CUMS-induced depression-like behaviors through the modulation of microbiota-gut-brain axis. Food Res Int. 2025;209:116214. doi: 10.1016/j.foodres.2025.116214 [DOI] [PubMed] [Google Scholar]
  • 57.Mao Q, Zhang H, Zhang Z, et al. Co-decoction of lilii bulbus and radix rehmannia recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis. Phytomedicine. 2024;129:155510. doi: 10.1016/j.phymed.2024.155510 [DOI] [PubMed] [Google Scholar]
  • 58.Liang HQ, Chen SD, Wang YJ, et al. Effect of hesperidin on chronic unpredictable mild stress-related depression in rats through gut-brain axis pathway. Chin J Integr Med. 2024;31(10):908–917. doi: 10.1007/s11655-024-3802-9 [DOI] [PubMed] [Google Scholar]
  • 59.Meng P, Zhang X, Li D, et al. Leonurine regulates hippocampal nerve regeneration in rats with chronic and unpredictable mild stress by activating SHH/GLI signaling pathway and restoring gut microbiota and microbial metabolic homeostasis. Neural Plast. 2023;2023:1455634. doi: 10.1155/2023/1455634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Deng L, Zhou X, Tao G, et al. Ferulic acid and feruloylated oligosaccharides alleviate anxiety and depression symptom via regulating gut microbiome and microbial metabolism. Food Res Int. 2022;162:111887. doi: 10.1016/j.foodres.2022.111887 [DOI] [PubMed] [Google Scholar]
  • 61.Song X, Wang W, Ding S, Liu X, Wang Y, Ma H. Puerarin ameliorates depression-like behaviors of with chronic unpredictable mild stress mice by remodeling their gut microbiota. J Affect Disord. 2021;290:353–363. doi: 10.1016/j.jad.2021.04.037 [DOI] [PubMed] [Google Scholar]
  • 62.Wu R, Tao W, Zhang H, et al. Instant and persistent antidepressant response of gardenia yellow pigment is associated with acute protein synthesis and delayed upregulation of BDNF expression in the hippocampus. ACS Chem Neurosci. 2016;7:1068–1076. doi: 10.1021/acschemneuro.6b00011 [DOI] [PubMed] [Google Scholar]
  • 63.Chen Y, Wang R, Li X, et al. Progress of research on the treatment of depression by traditional Chinese medicine prescriptions. Heliyon. 2024;10:e34970. doi: 10.1016/j.heliyon.2024.e34970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Yu M, Jia HM, Zhang T, et al. Gut microbiota is the key to the antidepressant effect of chaihu-shu-gan-san. Metabolites. 2020;10:63. doi: 10.3390/metabo10020063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Zeng M, Gong A, Wu Z. Paroxetine combined with traditional Chinese medicine prescriptions in the treatment of postpartum depression: a systematic review of randomized controlled trials. Front Neuroendocrinol. 2022;67:101019. doi: 10.1016/j.yfrne.2022.101019 [DOI] [PubMed] [Google Scholar]
  • 66.Fan Q, Liu Y, Sheng L, et al. Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway. Biomed Pharmacother. 2023;160:114385. doi: 10.1016/j.biopha.2023.114385 [DOI] [PubMed] [Google Scholar]
  • 67.Jiao H, Fan Y, Gong A, Li T, Fu X, Yan Z. Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus. J Ethnopharmacol. 2024;318:116938. doi: 10.1016/j.jep.2023.116938 [DOI] [PubMed] [Google Scholar]
  • 68.Sun C, Gao M, Qiao M. Research progress of traditional Chinese medicine compound “Xiaochaihu Decoction” in the treatment of depression. Biomed Pharmacother. 2023;159:114249. doi: 10.1016/j.biopha.2023.114249 [DOI] [PubMed] [Google Scholar]
  • 69.Tian X, Wang G, Teng F, et al. Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota-gut-brain axis in corticosterone combined with chronic restraint stress-induced mice. CNS Neurosci Ther. 2024;30:e14519. doi: 10.1111/cns.14519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Tan J, Li X, Zhu Y, et al. Antidepressant shugan jieyu capsule alters gut microbiota and intestinal microbiome function in rats with chronic unpredictable mild stress -induced depression. Front Pharmacol. 2022;13:828595. doi: 10.3389/fphar.2022.828595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Qu S, Liu M, Cao C, et al. Chinese medicine formula kai-xin-san ameliorates neuronal inflammation of CUMS-induced depression-like mice and reduces the expressions of inflammatory factors via inhibiting TLR4/IKK/NF-κB pathways on BV2 cells. Front Pharmacol. 2021;12:626949. doi: 10.3389/fphar.2021.626949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Shao S, Jia R, Zhao L, et al. Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway. Phytomedicine. 2021;88:153606. doi: 10.1016/j.phymed.2021.153606 [DOI] [PubMed] [Google Scholar]
  • 73.Cao C, Liu M, Qu S, et al. Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system. J Ethnopharmacol. 2020;261:113055. doi: 10.1016/j.jep.2020.113055 [DOI] [PubMed] [Google Scholar]
  • 74.Zhu HZ, Liang YD, Ma QY, et al. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Biomed Pharmacother. 2019;112:108621. doi: 10.1016/j.biopha.2019.108621 [DOI] [PubMed] [Google Scholar]
  • 75.Zhu KY, Mao QQ, Ip SP, et al. A standardized Chinese herbal decoction, kai-xin-san, restores decreased levels of neurotransmitters and neurotrophic factors in the brain of chronic stress-induced depressive rats. Evid Based Complement Alternat Med. 2012;2012:149256. doi: 10.1155/2012/149256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.XUsheng Tian NH, Lin S, Xiujun Y. Wei Cheng: experimental study on the effects of Suanzaoren decoction on the behavior and hippocampal BDNF and TrKB of depression model rats. Acta Chin Med Pharmacol. 2011;39:30–31. [Google Scholar]
  • 77.Dongsheng yan XZ, Fengmin D, Ping W. The effect of yueju pill to the ethology, 5–HT and blood plasm cortisol of depressive disorder mouse. J Jiangxi Univ Ersity TCM. 2007;19:64–67. [Google Scholar]
  • 78.Cai W, Wei XF, Zhang JR, et al. Acupuncture ameliorates depression-like behavior of poststroke depression model rats through the regulation of gut microbiota and NLRP3 inflammasome in the colon. Neuroreport. 2024;35:883–894. doi: 10.1097/WNR.0000000000002076 [DOI] [PubMed] [Google Scholar]
  • 79.Qi S, Qian J, Li Y, Li Y, Li W, Gao X. Effect of acupuncture at back-shu points on gut microbiota in insomnia model rats based on metagenomic sequencing technology. Front Microbiol. 2025;16:1541958. doi: 10.3389/fmicb.2025.1541958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Cai W, Ma W, Chen AW, Shen WD. Effects of electroacupuncture therapy for depression: study protocol for a multicentered, randomized controlled trial. Medicine. 2020;99:e22380. doi: 10.1097/MD.0000000000022380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Li Z, Li L, Xu H, et al. Modulating gut microbiota: the mechanism of electroacupuncture at the “Siguan” acupoints in alleviating post-stroke depression. Neuropsychiatr Dis Treat. 2025;21:281–294. doi: 10.2147/NDT.S495460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Xie J, Li J, Sun Q, Jiang J. Clinical efficacy of mind-regulating acupuncture on post-stroke depression based on the “Microbiota-gut-brain axis” theory: a randomized controlled study. Neuropsychiatr Dis Treat. 2025;21:1349–1358. doi: 10.2147/NDT.S525238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Li S, Huang J, Luo D, Fu W, Liu J. Electro-acupuncture inhibits HDAC2 via modulating gut microbiota to ameliorate SNI-induced pain and depression-like behavior in rats. J Affect Disord. 2024;360:305–313. doi: 10.1016/j.jad.2024.02.069 [DOI] [PubMed] [Google Scholar]
  • 84.Wang J, Zhu H, Song X, et al. Electroacupuncture regulates gut microbiota to reduce depressive-like behavior in rats. Front Microbiol. 2024;15:1327630. doi: 10.3389/fmicb.2024.1327630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Duan DM, Wang YC, Hu X, et al. Effects of regulating gut microbiota by electroacupuncture in the chronic unpredictable mild stress rat model. Neuroscience. 2024;557:24–36. doi: 10.1016/j.neuroscience.2024.08.005 [DOI] [PubMed] [Google Scholar]
  • 86.Wei JQ, Bai J, Zhou CH, et al. Electroacupuncture intervention alleviates depressive-like behaviors and regulates gut microbiome in a mouse model of depression. Heliyon. 2024;10:e30014. doi: 10.1016/j.heliyon.2024.e30014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Qiu X, Li Z, Huang S, et al. Electroacupuncture improves depression-like behavior by regulating the abundance of lactobacillus and staphylococci in mice. J Integr Neurosci. 2023;22:28. doi: 10.31083/j.jin2202028 [DOI] [PubMed] [Google Scholar]
  • 88.Cai W, Wei XF, Hu C, Ji J, Cui HS, Shen WD. Effects of electroacupuncture on gut microbiota and fecal metabolites in rats with poststroke depression. Neuropsychiatr Dis Treat. 2023;19:1581–1592. doi: 10.2147/NDT.S415098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Chen W, Chen Y, Aslam MS, et al. The effect of acupuncture on lateral habenular nucleus and intestinal microflora in depression model rats. Behav Brain Res. 2023;455:114627. doi: 10.1016/j.bbr.2023.114627 [DOI] [PubMed] [Google Scholar]
  • 90.Meng Q, Song C, Ma J, et al. Quercetin prevents hyperuricemia associated with gouty arthritis by inactivating the NLRP3/NF-κB signaling pathway. Chem Biol Drug Des. 2025;105:e70103. doi: 10.1111/cbdd.70103 [DOI] [PubMed] [Google Scholar]
  • 91.Lu K, Li C, Men J, et al. Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota. Front Microbiol. 2024;15:1409128. doi: 10.3389/fmicb.2024.1409128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Xia X, Zhang Y, Zhu L, et al. Liquiritin apioside alleviates colonic inflammation and accompanying depression-like symptoms in colitis by gut metabolites and the balance of Th17/Treg. Phytomedicine. 2023;120:155039. doi: 10.1016/j.phymed.2023.155039 [DOI] [PubMed] [Google Scholar]
  • 93.Luo T, Che Q, Guo Z, Song T, Zhao J, Xu D. Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis. Front Pharmacol. 2024;15:1442854. doi: 10.3389/fphar.2024.1442854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Farzi A, Fröhlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15:5–22. doi: 10.1007/s13311-017-0600-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Xie Y, Zhu H, Yuan Y, Guan X, Xie Q, Dong Z. Baseline gut microbiota profiles affect treatment response in patients with depression. Front Microbiol. 2024;15:1429116. doi: 10.3389/fmicb.2024.1429116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125:926–938. doi: 10.1172/JCI76304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Jadhav VV, Han J, Fasina Y, Harrison SH. Connecting gut microbiomes and short chain fatty acids with the serotonergic system and behavior in Gallus gallus and other avian species. Front Physiol. 2022;13:1035538. doi: 10.3389/fphys.2022.1035538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Bo M, Zhang H, Xu J, et al. Systematic review of Kaixinsan in treating depression: efficacy and pharmacological mechanisms. Front Behav Neurosci. 2022;16:1061877. doi: 10.3389/fnbeh.2022.1061877 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276. doi: 10.1016/j.cell.2015.02.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Liu P, Liu Z, Wang J, et al. Immunoregulatory role of the gut microbiota in inflammatory depression. Nat Commun. 2024;15:3003. doi: 10.1038/s41467-024-47273-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Chen C, Wang GQ, Li DD, Zhang F. Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Biomed. 2025;6:64. doi: 10.1186/s43556-025-00307-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128–133. doi: 10.1016/j.brainres.2018.03.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Qu S, Yu Z, Zhou Y, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res. 2024;287:127858. doi: 10.1016/j.micres.2024.127858 [DOI] [PubMed] [Google Scholar]
  • 104.Bai G, Jing S, Cao H, et al. Kai-Xin-San protects depression mice against CORT-Induced neuronal injury by inhibiting microglia activation and oxidative stress. Evid Based Complement Alternat Med. 2022;2022:5845800. doi: 10.1155/2022/5845800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Bistas KG, Tabet JP. The benefits of prebiotics and probiotics on mental health. Cureus. 2023;15:e43217. doi: 10.7759/cureus.43217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology. 1997;134:319–329. doi: 10.1007/s002130050456 [DOI] [PubMed] [Google Scholar]
  • 107.Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367–370. doi: 10.1007/BF00428203 [DOI] [PubMed] [Google Scholar]

Articles from Neuropsychiatric Disease and Treatment are provided here courtesy of Dove Press

RESOURCES